knowledge -WSS

knowledge

author：leisure time 2025-08-26 07:42:25 - browse：52359

President Biden's White House announced the first 10 medicines that will be up first in its new drug price negotiation program. Anna Moneymaker/Getty Images

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

The new prices will be announced on Sept. 1, 2024, and will go into effect on Jan. 1, 2026. The drugs were chosen from a list of 50 treatments that cost Medicare’s pharmacy drug benefit the most money. The selected medicines cost Medicare more than $50 billion and made up 20% of the Medicare program’s pharmacy drug costs over a one-year period, the Department of Health and Human Services said. (Read more here about the winners and losers of the selection.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Boston's new lab space is opening empty

WSS

Senate panel eyes new effort on drug shortages

Liquid biopsy for lung cancer is launched by Delfi

Pushing for an NIH office for post

FDA panel signals lack of confidence in Amgen cancer drug data

FDA authorizes Novavax’s updated Covid

Analysis of telehealth claims data suggest service duplication

hotspot

knowledge

leisure time

Guidelines to prevent youth baseball injuries need more muscle

A virus, fished out of a lake, may have saved a man’s life

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Duchenne breakthrough therapy leaves behind pioneering families

Histogen: Failed biotech offers rare public look inside

United colonoscopy coverage change 'may cost lives,' doctors say

RaDonda Vaught links Vanderbilt hospital issues to patient death

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

hotspot

FDA authorizes Novavax’s updated Covid

FDA authorizes Novavax’s updated Covid

Pushing for an NIH office for post

John Green on his newest strategy for fighting tuberculosis

John Green on his newest strategy for fighting tuberculosis

Sana to lay off nearly a third of staff, de

knowledge

hotspot

explore

entertainment